Daptomycin activity and spectrum: a worldwide sample of 6737 clinical Gram-positive organismsSTREIT, Jennifer M; JONES, Ronald N; SADER, Helio S et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, Num 4, pp 669-674, issn 0305-7453, 6 p.Article

Validation of commercial dry-form broth microdilution panels and test reproducibility for susceptibility testing of dalbavancin, a new very long-acting glycopeptideJONES, Ronald N; STREIT, Jennifer M; FRITSCHE, Thomas R et al.International journal of antimicrobial agents. 2004, Vol 23, Num 2, pp 197-199, issn 0924-8579, 3 p.Article

Cefdinir activity against contemporary North American isolates from community-acquired urinary tract infectionsSADER, Helio S; BIEDENBACH, Douglas J; STREIT, Jennifer M et al.International journal of antimicrobial agents. 2005, Vol 25, Num 1, pp 89-92, issn 0924-8579, 4 p.Article

Potency and spectrum reevaluation of cefdinir tested against pathogens causing skin and soft tissue infections: a sample of North American isolatesSADER, Helio S; STREIT, Jennifer M; FRITSCHE, Thomas R et al.Diagnostic microbiology and infectious disease. 2004, Vol 49, Num 4, pp 283-287, issn 0732-8893, 5 p.Article

Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwideSADER, Helio S; STREIT, Jennifer M; FRITSCHE, Thomas R et al.Diagnostic microbiology and infectious disease. 2004, Vol 50, Num 3, pp 201-204, issn 0732-8893, 4 p.Article

Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovisSTREIT, Jennifer M; STEENBERGEN, Judith N; THORNE, Grace M et al.Journal of antimicrobial chemotherapy (Print). 2005, Vol 55, Num 4, pp 574-578, issn 0305-7453, 5 p.Article

Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolatesSTREIT, Jennifer M; FRITSCHE, Thomas R; SADER, Helio S et al.Diagnostic microbiology and infectious disease. 2004, Vol 48, Num 2, pp 137-143, issn 0732-8893, 7 p.Article